GHB Poisoning and Poisoning Induced by Others
NCT03651778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2024-12-11
Summary
Patients with suspected GHB poisoning presenting to Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) or a hospital in Oslo (Oslo University Hospital Ullevål, Diakonhjemmet, Lovisenberg) will be included. Oral fluid and blood tests will be analyzed for recreational drugs. Clinical course will be charted, as well as treatment in the ambulance, emergency outpatient clinic and hospital to find predictors for when hospitalization is required.
In the second part of the study the investigators will analyze urine and blood samples from patients presenting to the Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) with suspected substance poisoning induced by others, for toxic agents.
Conditions
- Drug Toxicity
Sponsors & Collaborators
-
Lovisenberg Diakonale Hospital
collaborator OTHER -
Diakonhjemmet Hospital
collaborator OTHER -
Oslo University Hospital
collaborator OTHER -
University of Oslo
collaborator OTHER -
Oslo Accident and Emergency Outpatient Clinic
collaborator UNKNOWN -
Odd Martin Vallersnes
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2023-11-01
- Completion
- 2023-11-01
Countries
- Norway
Study Locations
More Related Trials
-
Characterization of the Prosocial and Prosexual Effects of GHB
NCT02342366 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Acute Self-poisoning in Emergency Services in France
NCT02518386 ·Status: COMPLETED
-
Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.
NCT00967421 ·Status: COMPLETED ·Phase: NA
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
GCS Survey: "GHB IN CHEMICAL SUBMISSION: MYTH OR REALITY?"
NCT06137599 ·Status: RECRUITING
-
Divided Drug Delivery
NCT02869724 ·Status: UNKNOWN ·Phase: NA
-
Characteristics of Spiking in Ghent: a Multicentric Prospective Observational Study..
NCT06207396 ·Status: COMPLETED
-
A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users
NCT02094599 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of GH001 in Healthy Volunteers
NCT05163691 ·Status: COMPLETED ·Phase: PHASE1
-
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
NCT03056482 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Agitation in Emergency Psychiatry
NCT06752616 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults
NCT05906511 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat
NCT04322214 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
NCT07333131 ·Status: RECRUITING
-
Brain Activity Under the Influence of JWH
NCT06044415 ·Status: UNKNOWN ·Phase: NA
-
Rapid Agitation Control With Ketamine in the Emergency Department
NCT03375671 ·Status: COMPLETED ·Phase: PHASE2
-
Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
NCT04336605 ·Status: UNKNOWN
-
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
NCT07246187 ·Status: RECRUITING ·Phase: PHASE3
-
Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH
NCT00176085 ·Status: COMPLETED
-
Neurological Recovery Following NOS-SACD
NCT05714917 ·Status: RECRUITING
-
Effects of Dronabinol (Oral THC) on Cannabis Use
NCT01394185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Norwegian Addiction, Pain and Trauma Study
NCT04908410 ·Status: ACTIVE_NOT_RECRUITING
-
Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines
NCT00650130 ·Status: COMPLETED
-
Effect of Fruit Smoothie Supplementation on Psychological Distress Among People Receiving Opioid Agonist Therapy
NCT05229770 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability and Human Pharmacology of Mephedrone
NCT02232789 ·Status: COMPLETED ·Phase: PHASE1